Compounds > 4-iodo-2,5-dimethoxyphenylisopropylamine
Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Rheumatoid Arthritis

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Rheumatoid Arthritis in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Snir, O1
Hesselberg, E1
Amoudruz, P1
Klareskog, L1
Zarea-Ganji, I1
Catrina, AI1
Padyukov, L1
Malmström, V1
Seddighzadeh, M1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Rheumatoid Arthritis

ArticleYear
Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.
    Genes and immunity, 2013, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amphetamines; Arthritis, Rheumatoid; Enterotoxins; Genetic Variation

2013